Adherence to Guidelines for Respiratory Syncytial Virus Immunoprophylaxis Among Infants With Prematurity or Chronic Lung Disease in Three United States Counties

    loading  Checking for direct PDF access through Ovid


Among infants with prematurity and/or chronic lung disease for whom respiratory syncytial virus immunoprophylaxis is recommended, we examined adherence in infants enrolled during healthcare visits for acute respiratory illness in 3 US counties from 2001 to 2007. Immunoprophylaxis among infants who met national criteria for prophylaxis increased from 33% to 83% over the 6-year period; 17% (11/65) of infants who received immunoprophylaxis did not meet eligibility criteria.

    loading  Loading Related Articles